The treatment and management of myeloproliferative neoplasms (MPNs) including myelofibrosis (MF) and polycythemia vera (PV) has transformed in recent years, although several challenges remain. There are ongoing clinical trials investigating the safety and efficacy of novel agents for this group of diseases, as well as strategies to improve the diagnosis and risk stratification of patients.
In this podcast, Lucia Masarova, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, Anthony Hunter, MD, Winship Cancer Institute of Emory University, Atlanta, GA, Jean-Jacques Kiladjian, MD, PhD, Saint-Louis Hospital & Paris Diderot University, Paris, France, and John Mascarenhas, MD, Mount Sinai Medical Center, New York, NY, discuss several updates in the field of MPNs. Topics covered include novel agents being explored in PV, clinical guidance for the use of JAK inhibitors in MF, and the growing role of combination approaches.
CAR T-cell therapy & multiple myeloma: past, present & future
Harnessing the tumor microenvironment in lymphoma therapy
Induction therapy in myeloma: an ever-changing paradigm
Precision epigenetic therapy for B-cell lymphoma
Acute leukemia: pushing boundaries in disease management
iwAL 2019: looking to the future of acute leukemia therapy
CAR T-cell therapy and precision medicine in non-Hodgkin lymphoma
MRD testing in multiple myeloma: new technology with promising clinical applications
CAR T-cells in myeloma: exploratory targets, payment models & treatment sequence
Patient discussion at EHA 2018: CAR T-cells and MRD in CLL
CLL therapies today: novel agents, combinations & the future of the field
CAR T-cell therapy: where are we now and what’s in store for the future?
Focus on MRD: current landscape and future questions in hemonc
Acute leukemias discussion: what does genomics and epigenomics tell us about patient management?
Acute leukemias: is MRD already a surrogate for survival?
Revolutionary immunotherapies for lymphoma
Latest advances and current challenges in immunotherapies for lymphoma
The circle of CLL: from gene discovery to targeted treatment
Debate on the use of MRD for multiple myeloma management
Myeloma 2017 day 1 highlights: immunotherapy advances, a new MM subtype and liquid biopsies
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Good Nurse Bad Nurse
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
The Peter Attia Drive
The Doctor’s Farmacy with Mark Hyman, M.D.